申请人:Miles Laboratories, Inc.
公开号:US04110536A1
公开(公告)日:1978-08-29
Derivatives of 5-(indol-3-yl)hydantoin characterized by the generic structural formula, ##STR1## and their pharmacologically compatible salts are useful in the treatment of cardiac arrythmias in individuals for whom such therapy is indicated. In the preceding structural formula, A is a hydrogen atom, a halogeno, alkyl, hydroxyl, or an alkoxyl radical; n is 0 or 1; R is a hydrogen atom or a phenyl group; X is a methylene, ethylene, trimethylene, or 2-hydroxytrimethylene radical; and Z is a monoalkylamino radical containing 1-4 carbon atoms, a dialkylamino radical containing 2-8 carbon atoms, a morpholino, piperid-1-yl, 4-phenyl-piperid-1-yl, or a 4-hydroxy-4-phenyl-piperid-1-yl radical.
5-(indol-3-yl)hydantoin的衍生物具有通用结构式##STR1##,其药理学兼容的盐在需要此类治疗的个体中用于治疗心律失常。在上述结构式中,A是氢原子,卤素基,烷基,羟基或烷氧基;n为0或1;R是氢原子或苯基;X是亚甲基,乙烯基,三亚甲基或2-羟基三亚甲基基团;Z是含有1-4个碳原子的单烷基氨基基团,含有2-8个碳原子的双烷基氨基基团,吗啡啶基,哌啶-1-基,4-苯基哌啶-1-基或4-羟基-4-苯基哌啶-1-基基团。